The inhibitory effects of myricitrin on the oxidation of human low-density lipoprotein were investigated before and after its degradation by simulated digestion. Myricitrin strongly inhibited the low-density lipoprotein oxidation induced by either 2,2 0 -azobis (2-amidinopropane) dihydrochloride or CuSO 4 in a concentrationdependent manner. Myricitrin was very stable under an acidic condition (pH 1.8) corresponding to the gastric environment, but it was easily degraded under an alkaline condition (pH 8.5) corresponding to the intestinal environment. However, degraded myricitrin also had a strong inhibitory effect on the oxidative degradation of -tocopherol, cholesterol and apolipoprotein B-100 in low-density lipoprotein. Our study revealed that myricitrin was degraded into many components under a mildly alkaline condition, but the degraded myricitrin still retained the free radical-scavenging and copperchelating activities toward low-density lipoprotein.
The inhibitory effects of myricitrin on the oxidation of human low-density lipoprotein were investigated before and after its degradation by simulated digestion. Myricitrin strongly inhibited the low-density lipoprotein oxidation induced by either 2,2 0 -azobis (2-amidinopropane) dihydrochloride or CuSO 4 in a concentrationdependent manner. Myricitrin was very stable under an acidic condition (pH 1.8) corresponding to the gastric environment, but it was easily degraded under an alkaline condition (pH 8.5) corresponding to the intestinal environment. However, degraded myricitrin also had a strong inhibitory effect on the oxidative degradation of -tocopherol, cholesterol and apolipoprotein B-100 in low-density lipoprotein. Our study revealed that myricitrin was degraded into many components under a mildly alkaline condition, but the degraded myricitrin still retained the free radical-scavenging and copperchelating activities toward low-density lipoprotein.
Key words: myricitrin; flavonoid; low-density lipoprotein; oxidation; atherosclerosis Atherosclerosis is characterized by an accumulation of arterial foam cells mainly derived from oxidized lowdensity lipoprotein (LDL)-loaded macrophages. Macrophage-scavenging receptors recognize oxidized LDL, but not native LDL. LDL containing cholesterol, fatty acid, phospholipids and apolipoprotein B-100 (ApoB) is easily oxidized by factors such as free radicals and metal ions. Hence, inhibiting LDL oxidation may play an important role in preventing the development of atherosclerosis.
There are many reports that a dietary intake of flavonoids prevents LDL oxidation. The total amount of flavonoid intake has been reported to be 10 mg to 1 g per day and is mainly from tea, onions, apples, and red wine. 1) Those diets with an antioxidative potential are enriched with various types of flavonoid such as catechin and quercetin. However, it is still unclear which flavonoid is the most effective in preventing LDL oxidation. Flavonoids can act as potent inhibitors of LDL oxidation via such mechanisms as metal-ion chelation and free-radical scavenging. 2, 3) Myricetin has been reported to have a strong inhibitory effect on LDL oxidation. 1, 4) In previous studies, only the effect of the aglycon of myricetin was investigated, although myricetin is unstable and usually contained in plants in the form of the more stable glycoside, myricitrin. Furthermore, recent findings have suggested that flavonoids were unstable under a mildly alkaline condition. 5) Typical pH values for human plasma, bile, intestinal juice and pancreatic juice are 7.4, 7.1-8.5, 8.3 and 7.0-8.5, respectively, and unstable flavonoids may be degraded in a mildly alkaline biological milieu. 6) Myricitrin is a rhamnose glycoside of myricetin contained in various plants. [7] [8] [9] However, there have only been a few reports on myricitrin, regardless of its strong antioxidative effect. 10) Moreover, there have been no reports on the relationship between the stability under a biogenic condition and the antioxidative activity of myricitrin toward LDL. In this present study, the antioxidative activity of myricitrin toward LDL was investigated before and after its degradation by simulated digestion. In addition, the antioxidative effect of degraded myricitrin on -tocopherol, cholesterol and ApoB was also investigated in the presence of the 2,2 0 -azobis (2-amidinopropane) dihydrochloride (AAPH) radical.
Materials and Methods
Reagents. Myricitrin was purchased from Funakoshi Co. (Tokyo, Japan) and rutin, myricetin, quercetin, kaempferol, luteolin and apigenin were purchased from Sigma Chemical Co. (St. Louis, MO, U.S.A.). Figure 1 shows the structures of the individual flavonoids. LDL (5 mg protein/ml, from human plasma) was purchased from Sigma Chemical Co. and stored at 4 C in the dark until its use. AAPH, CuSO 4 , 1,1-diphenyl-2-picrylhyy To whom correspondence should be addressed. Fax: +81-6-6333-3531; E-mail: mmoriwaki@saneigenffi.co.jp Abbreviations: LDL, low-density lipoprotein; ApoB, apolipoprotein B-100; AAPH, 2,2 0 -azobis (2-amidinopropane) dihydrochloride; DPPH, 1,1-diphenyl-2-picrylhydrazyl; TEP, 1,1,3,3-tetraethoxypropane; TBA, thiobarbituric acid; TBARS, thiobarbituric acid-reactive substance; BHT, butylated hydroxytoluene; MDA, malondialdehyde; HPLC, high performance liquid chromatography; TFA, trifluoroacetic acid; DM, degraded myricitrin; MS, mass spectrometry; PAGE, polyacrylamide gel electrophoresis drazyl (DPPH) and 1,1,3,3-tetraethoxypropane (TEP) were purchased from Wako Pure Chemicals Co. (Osaka, Japan).
LDL oxidation. The EDTA-containing human LDL solution was dialyzed against a 100-fold volume of 0.01 M phosphate buffer (pH 7.4, 0.16 M NaCl) which had been freed from oxygen by vacuum degassing.
11)
The buffer was changed four times. This EDTA-free LDL stock solution was used for all the oxidation studies. The stock solution was stored at 4 C, but not for longer than 24 h. The protein content was determined by the Lowry method, using a DC protein assay kit (BioRad Co., Hercules, CA, U.S.A.).
12) The EDTA-free LDL stock solution was diluted to 100 mg protein/ml with oxygen-saturated 0.01 M phosphate buffer (pH 7.4), and the subsequent LDL oxidation was initiated by adding aqueous a 10 mM AAPH or 12 mM CuSO 4 solution at 37 C. After the incubation, the oxidation degree of LDL was measured by the thiobarbituric acid (TBA) method.
Thiobarbituric acid-reactive substance (TBARS). TBARS produced from LDL by the oxidation reaction were measured by the modified TBA method of Ohkawa et al. 13) A 0.6-ml aliquot of the LDL solution was mixed with 0.5 ml of a 35% trichloroacetic acid solution, 1 ml of a 0.5% TBA solution, 0.05 ml of a 0.22% butylated hydroxytoluene (BHT) ethanol solution, and 0.05 ml of a 0.5% SDS solution in a test tube. The tube was tightly closed with a screw cap and placed in a water bath at 100 C for 30 min. After cooling in an ice bath, 0.5 ml of acetic acid and 1 ml of chloroform were added, and the test tube was shaken vigorously for 30 s. After centrifugation at 3,000 rpm for 10 min, the absorbance of the upper layer at 532 nm was measured with a spectrophotometer (V-550, Jasco Co., Tokyo, Japan). In this study, malondialdehyde (MDA) produced from TEP was used as a reference standard, the results being expressed as an MDA equivalent in nmol.
DPPH radical-scavenging activity. The free radicalscavenging activity was determined by using the stable DPPH radical according to the method of Blois with a modification. 14) A 2-ml sample of a methanol solution at each concentration was added to 2 ml of a 300 mM DPPH methanol solution, mixed vigorously and kept for 30 min at 37 C in the dark. The radical-scavenging activity was quantified by the decolorization of DPPH measured at 517 nm.
Copper-chelating ability. The copper-chelating ability of myricitrin was determined by the method of Nardini et al. 15) The spectral shift of myricitrin in the 200-600 nm range after adding an equimolar copper solution were monitored by spectrophotometry. The reaction mixture consisted of 2 ml of 100 mM myricitrin and 2 ml of 100 mM CuSO 4 prepared with a 0.01 M phosphate buffer (pH 7.4). The effect on the spectral shift of adding equimolar EDTA to the myricitin-copper complex was also investigated.
Stability of myricitrin at various pH values. The stability of myricitrin was examined at various pH values (1.8-8.5). 6, 16) A 100 mM myricitrin solution was prepared with simulated gastric juice (a 0.24% hydrochloric acid À0:2% sodium chloride solution at pH 1.8), a 0.05 M phosphate buffer (pH 5.0, 6.0, 7.0, 7.4 or 8.0), or simulated intestinal juice (a 1.5% sodium hydrogen carbonate solution at pH 8.5), each solution being incubated at 37 C while stirring. An aliquot of the incubated solution was periodically analyzed by high performance liquid chromatography (HPLC, Agilent 1100, Agilent technologies Co., Palo Alto, CA, U.S.A.) with a TSKgel ODS-120T reversed-phase column (4:6 Â 250 mm, Tosoh Co., Tokyo, Japan). Mobile phase A consisted of 0.05% trifluoroacetic acid (TFA) in water and phase B consisted of 0.05% TFA in methanol. The flow rate was 0.8 ml/min, and the linear gradient of phase B changed from 0 to 100% in 30 min. Myricitrin was monitored by HPLC with diode array detection at 363 nm.
Degraded myricitrin (DM).
Myricitrin digestion was simulated essentially as described by Yoshono et al. 16) After incubating 100 mM myricitrin at 37 C for 60 min in simulated gastric juice (a 0.24% hydrochloric acid À0:2% sodium chloride solution at pH 1.8), the solution was adjusted to pH 8.5 by adding sodium carbonate and incubated for another 60 min. After this simulated digestion, degraded myricitrin (DM) was neutralized, and the antioxidative activity of DM was investigated at a concentration equal to the myricitrin concentration before degradation.
Measurement of -tocopherol. The consumption of - tocopherol in LDL (200 mg protein/ml) by oxidation with 1 mM AAPH was monitored by HPLC. 17) An aliquot of the LDL reaction solution (2 ml) was periodically sampled and chilled on ice. Before the measurement, 100 ml of a 0.5% BHT ethanol solution was added as an antioxidant, and -tocopherol was immediately extracted with 5 ml of n-hexane. The n-hexane layer was then evaporated under a gentle stream of nitrogen, and the resulting extract was redissolved in 200 ml of ethanol. The amount of -tocopherol in the ethanol extract solution was analyzed by HPLC/mass spectrometry (MS) with an Alliance ZQ2000 LC/MS system (Waters Co., Milford, MA, U.S.A.), using a reversedphase XTerra MS C18 column (2:1 Â 150 mm, Waters Co.). -tocopherol was eluted with methanol at a flow rate of 0.8 ml/min and monitored with a diode array detector at 292 nm. The initial concentration oftocopherol in the final incubation solution of LDL was 2.69 mM.
Measurement of total cholesterol. Total cholesterol in LDL (200 mg protein/ml) after degradation with 10 mM AAPH was enzymatically measured with a Determiner L LDL-C kit (Kyowa medics Co., Tokyo, Japan), using cholesterol esterase and cholesterol oxidase. The initial concentration of total cholesterol in the LDL solution was 72.42 mg/dl.
Polyacrylamide gel electrophoresis (PAGE) for measuring ApoB. ApoB fragmented from LDL (200 mg protein/ml) by the treatment with 10 mM AAPH was detected by SDS-PAGE. The LDL reaction solution (0.1 ml) was mixed with the same volume of a sample buffer containing 1% SDS, 20% glycerol, 1% 2-mercaptoethanol and a 0.05 M Tris-HCl buffer (pH 6.8). This mixture was heated in a water bath at 100 C for 3 min. A sample (10 ml) and molecular weight marker (High SDS-PAGE standard, Bio-Rad Co.) were loaded on to 3-10% gradient gel (PAGEL NPG310L, Atto Co., Tokyo, Japan), and 20 mA was applied for 75 min. The gel was then stained with Quick CBB (Coomassie brilliant blue R 250, Wako Pure Chemicals Co.).
Statistical analysis. Each data point represents the mean of 3-6 replicated samples and a result is expressed as the mean AE SD. Differences between means were compared by using one-way ANOVA. Two-way AN-OVA for repeated measurements was used to compare data in the time-course experiments. A post-hoc analysis for significant mean differences between the effects of various antioxidants was done by using the TukeyKramer HSD test and Dunnett test.
Results and Discussion
Antioxidative activity of myricitrin Many flavonoids have strong antioxidative activity for LDL. According to Zhu et al., kaempferol and morin were less effective than myricetin and quercetin for inhibiting the LDL oxidation induced by AAPH and CuSO 4 . 4) McAnlis et al. have compared the antioxidative effect of each flavonoid toward LDL in the presence of AAPH and CuSO 4 , and found that the effect was in the order of quercetin > rutin > myricetin > kaempferol > apigenin. 1) However, this order varied with the experimental conditions. We compared the inhibitory effect of myricitrin and other flavonoids on the LDL oxidation induced by the AAPH radical with the TBA method. The antioxidative activity of a flavonoid is said to be derived from its metal ion-chelating and radicalscavenging activity. In this study, to investigate the effects of the radical-scavenging activity of flavonoids, we mainly used the AAPH radical to oxidize LDL rather than CuSO 4 , and found that 77.9% of the oxidation induced by 10 mM AAPH was inhibited by adding 50 mM myricitrin, as shown in Fig. 2 . Myricitrin and myricetin each showed strong antioxidative activity, but the effects of kaempferol and apigenin were rather weak. The number and location of hydroxyl groups are important for the radical-scavenging activity of a flavonoid. 18) We found that the antioxidative activity of myricitrin is slightly decreased by rhamnose glycosilation at the 3-position of a hydroxyl group of myricetin. Myricetin is more lipophilic than myricitrin; hence, myricetin can protect LDL from oxidation more easily than myricitrin. Salah et al. have also reported that the radical-scavenging activity of rutin was weaker than that of the aglycon, quercetin, because of glycosilation at the 3-position of the hydoroxyl group. 19) The inhibitory effect of myricitrin at various concentrations on the LDL oxidation induced by 10 mM AAPH and by 12 mM CuSO 4 was investigated (Table 1) . With both oxidation systems, myricitrin prevented the oxidative formation of TBARS in a concentration-dependent manner. The addition of 100 mM myricitrin prevented 88.8% AAPH radical-induced and 95.5% copper-induced TBARS formation. Myricitrin was more effective in inhibiting the oxidation induced by CuSO 4 than that induced by the AAPH radical.
Furthermore, myricitrin showed strong concentrationdependent scavenging activity, even toward the stable free radical, DPPH (Table 2) .
Copper chelation
The spectrum of a flavonoid solution is characteristically changed by the presence of metal ions. 2, 3, 15) The interaction between myricitrin and copper in an LDLfree phosphate buffer was investigated (Fig. 3) . The peaks of the spectrum were shifted rapidly by adding equimolar copper to the myricitrin solution (from 363 to 407 nm, and from 269 nm to 253 nm). Equimolar addition of EDTA to the myricitrin-copper complex solution recovered the spectral shift of myricitrin. The addition of copper to the myricitrin solution formed a copper-myricitrin complex, but a strong chelator such as EDTA chelated the copper, preventing the formation of copper-myricitrin. This result suggests that the ability of myricitrin to combine with the copper ion was weaker than that to combine with EDTA. Moreover, the shifted spectrum of the myricitrin-copper complex did not change for 60 min (data not shown), implying that the equimolar myricitrin-copper complex was stable in a phosphate buffer (pH 7.4). This indicates that myricitrin inhibits LDL oxidation by the chelating activity of the copper ion.
Stability of myricitrin
Myricitrin solutions (100 mM) prepared at various pH values were incubated at 37 C to investigate the stability of myricitrin under biogenic pH conditions (Fig. 4) . At pH 1.8, corresponding to the pH of human The spectrum of 50 mM myricitrin in a 0.01 M phosphate buffer (pH 7.4) was monitored just after adding 50 mM CuSO 4 and after incubating for 60 min. To another 50 mM myricitrin solution, 50 mM of EDTA was added 5 min after adding 50 mM CuSO 4 , and the spectrum was monitored after incubation for 60 min. Myricitrin (100 mM) was prepared in solution at various pH values, before being incubated at 37 C while stirring. The decrease in myricitrin concentration was monitored by HPLC, using a reversedphase column. Each data point shows the mean of triplicate measurements. gastric juice, myricitrin was very stable and did not degrade. However, under a mildly alkaline solution of pH 7.4 to 8.5 corresponding to that in intestinal juice, myricitrin was unstable and many components were produced depending on pH the value. This result suggests that myricitrin would be stable in the stomach, but unstable and degraded in human intestinal juice.
To investigate the antioxidative activity of myricitrin after its absorption in the intestines, we prepared degraded myricitrin (DM) by incubating a myricitrin solution at pH 8.5 after being at pH 1.8, which correspond to the gastric and intestinal pH values (Fig. 5) . Myricitrin was greatly degraded by 60 min incubation at pH 8.5, the peak area of myricitirn remaining after this incubation being only 2.4% of the original peak area of myricitrin. DM did not contain myricetin derived from alkaline degradation of myricitrin.
The spectrum of the main peaks in DM (P1-P3 in Fig. 5 ) was monitored by HPLC with a diode array detector (Fig. 6) . The shape of the spectrum was different from that of native myricitrin, although by only a little. This suggests that DM still retained its basic structure of myricitrin after modification under the mildly alkaline condition.
We investigated the inhibitory effect of DM on the LDL oxidation induced by AAPH and CuSO 4 ( Table 3) . The antioxidative activity of DM toward LDL gradually decreased with the progress of degradation. However, the inhibitory effect of DM on AAPH-induced LDL oxidation was only 25.8% less than that of myricitrin. Although DM contained a small amount of undegraded myricitrin, it showed stronger antioxidative activity than the remaining amount of myricitrin. This result suggests that myricitrin was degraded to many components in a mildly alkaline intestinal environment; however, the degradation products still maintained an inhibitory effect on LDL oxidation.
-Tocopherol consumption and cholesterol degradation
The presence of -tocopherol in LDL is known to play an important role in inhibiting LDL oxidation.
20)

Fig. 5. HPLC Profile of Myricitrin after Incubating under Simulated
Gastric and Intestinal Conditions. Myricitrin (100 mM) was incubated in simulated gastric juice for 60 min at pH 1.8, and then in intestinal juice at pH 8.5 for 60 min, before being analyzed by HPLC with a reversed-phase column. A myricitrin solution incubated under a simulated gastric condition (pH 1.8) and simulated intestinal condition (pH 8.5) was periodically sampled. After neutralization, 50 mM of each sample was added to the LDL solution (100 mg protein/ml) in a 0.01 M phosphate buffer (pH 7.4) containing 10 mM AAPH or 12 mM CuSO 4 at 37 C for 180 min. The oxidation degree was measured by the TBA method. MDA produced from TEP was used as a reference standard, and TBARS is expressed as nmol MDA equivalents. The myricitrin residual ratio indicates the peak area ratio of myricitrin in all peak area of myricitrin incubation solution at 363 nm. Control values were obtained without myricitrin. Each data point shows the mean AE SD (n ¼ 5{6). Values with different letters within a column are significantly different from each other (p < 0:05).
The effect of DM on the -tocopherol content in LDL was measured by HPLC in the presence of 1 mM AAPH at 37 C (Fig. 7) . The content of -tocopherol in LDL rapidly decreased in the absence of DM and reached zero after 2 h, but this decrease was significantly retarded by adding DM to the incubation solution, even 5 mM DM being effective. After a 2-h incubation in 5 mM DM together with 1 mM AAPH, the content oftocopherol was reduced by 66% compared with the control, but in the presence of 50 mM DM, it was reduced by only 28%. Thus, DM concentration-dependently prevented the AAPH-induced decrease of -tocopherol in LDL. In a 1 mM AAPH solution containing 10 and 50 mM DM, the content of -tocopherol in LDL rapidly and respectively decreased during the first 15 and 30 min, but it slightly increased again after 1.5 h. Such regeneration of -tocopherol observed when incubated in some flavonoids other than DM. According to Zhu et al., -tocopherol was regenerated in human LDL by adding 5 to 30 mM of green tea catechins. 17) This result suggests that DM prevented LDL oxidation by its hydrogen-donating ability to regenerate -tocopherol from the -tocopheryl radical. 21) Oxidized cholesterol is closely associated with heart disease as well as atherosclerosis. LDL consists of 38% cholesterol ester and 8% unesterified cholesterol.
22) The Polyunsaturated groups of esterified cholesterol in LDL are susceptible to oxidation. The amount of total cholesterol in LDL incubated in an AAPH solution containing DM at various concentrations was determined by an enzymatic method, using cholesterol oxidase (Fig. 8) .
About 71% of total cholesterol was oxidized and degraded within 9 h in 10 mM AAPH, but this degradation was retarded by the concentration-dependent addition of DM, the addition of 50 mM DM preventing the degradation by about 39%. This result suggests that DM also prevented the oxidative degradation of cholesterol in LDL.
Apolipoprotein B-100 (ApoB) fragmentation LDL constitutes about 21% of the lipoprotein mass, and more than 95% of this consists of apolipoprotein B-100 (ApoB). During the oxidation of LDL, the amino acids of ApoB are oxidized and ApoB is fragmented to polypeptides. The inhibitory effect of DM on the oxidative fragmentation of ApoB induced by AAPH was investigated by SDS-PAGE (Fig. 9) . The spot for ApoB protein completely disappeared when LDL was incubated with AAPH alone. The addition of 5 mM DM slightly inhibited the fragmentation of ApoB, and 10 mM DM suppressed it markedly. Myricitrin was also as effective as DM in this respect. DM thus inhibited the oxidative fragmentation of ApoB induced by AAPH concentration-dependently.
In conclusion, our experiments demonstrated that myricitrin and its alkaline degradation products (DM) prepared under the same mildly alkaline conditions as those in the human intestines had a strong inhibitory effect on the LDL oxidation induced by radical scavenging and metal-ion chelation. These results suggest that dietary myricitrin was degraded under biogenic mildly alkaline conditions during digestion, but C. The -tocopherol content in LDL was monitored at 292 nm by HPLC, using a reversed-phase column after extraction with n-hexane. The initial concentration of -tocopherol in the LDL solution was 2.69 mM. Control values were obtained without DM. ( ) control, ( ) 5 mM DM, ( ) 10 mM DM, ( ) 50 mM DM. Each data point shows the mean AE SD (n ¼ 4). Significant difference from the control (*p < 0:05, **p < 0:01). that the degraded product was still effective in preventing LDL oxidation. A further study will be necessary to identify the component of DM that inhibited LDL oxidation in human plasma. The results of the present study suggest that the intake of foods containing myricitrin would be effective for lowering the risk of atherosclerosis caused by LDL oxidation mediated by free radicals or metal ions. 
